Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

Stock Information for Coherus Oncology Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Coherus Oncology Inc.

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
Coherus Oncology to Participate in Upcoming Investor Conferences
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.